Literature DB >> 23510592

The role of asymptomatic P. falciparum parasitaemia in the evolution of antimalarial drug resistance in areas of seasonal transmission.

Hamza A Babiker1, Amal A H Gadalla, Lisa C Ranford-Cartwright.   

Abstract

In areas with seasonal transmission, proper management of acute malaria cases that arise in the transmission season can markedly reduce the disease burden. However, asymptomatic carriage of Plasmodium falciparum sustains a long-lasting reservoir in the transmission-free dry season that seeds cyclical malaria outbreaks. Clinical trials targeting asymptomatic parasitaemia in the dry season failed to interrupt the malaria epidemics that follow annual rains. These asymptomatic infections tend to carry multiple-clones, capable of producing gametocytes and infecting Anopheles mosquitoes. Different clones within an infection fluctuate consistently, indicative of interaction between clones during the long course of asymptomatic carriage. However, the therapy-free environment that prevails in the dry season dis-advantages the drug resistant lineages and favors the wild-type parasites. This review highlights some biological and epidemiological characteristics of asymptomatic parasitaemia and calls for consideration of policies to diminish parasite exposure to drugs "therapy-free" and allow natural selection to curb drug resistance in the above setting.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510592     DOI: 10.1016/j.drup.2013.02.001

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  18 in total

Review 1.  Malaria Pathogenesis.

Authors:  Danny A Milner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  Asymptomatic Multiclonal Plasmodium falciparum Infections Carried Through the Dry Season Predict Protection Against Subsequent Clinical Malaria.

Authors:  Klara Sondén; Safiatou Doumbo; Ulf Hammar; Manijeh Vafa Homann; Aissata Ongoiba; Boubacar Traoré; Matteo Bottai; Peter D Crompton; Anna Färnert
Journal:  J Infect Dis       Date:  2015-02-23       Impact factor: 5.226

3.  A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.

Authors:  A Ruecker; D K Mathias; U Straschil; T S Churcher; R R Dinglasan; D Leroy; R E Sinden; M J Delves
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

Review 4.  The interplay between drug resistance and fitness in malaria parasites.

Authors:  Philip J Rosenthal
Journal:  Mol Microbiol       Date:  2013-08-16       Impact factor: 3.501

5.  NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria.

Authors:  Maria de Jesus Trovoada; Madalena Martins; Riadh Ben Mansour; Maria do Rosário Sambo; Ana B Fernandes; Lígia Antunes Gonçalves; Artur Borja; Roni Moya; Paulo Almeida; João Costa; Isabel Marques; M Paula Macedo; António Coutinho; David L Narum; Carlos Penha-Gonçalves
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

6.  Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.

Authors:  Hanna Y Ehrlich; Amy K Bei; Daniel M Weinberger; Joshua L Warren; Sunil Parikh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 12.779

7.  Application of magnetic cytosmear for the estimation of Plasmodium falciparum gametocyte density and detection of asexual stages in asymptomatic children.

Authors:  Deborah Sumari; Brian T Grimberg; D'Arbra Blankenship; Joseph Mugasa; Kefas Mugittu; Lee Moore; Paul Gwakisa; Maciej Zborowski
Journal:  Malar J       Date:  2016-02-24       Impact factor: 2.979

8.  Numerical Distributions of Parasite Densities During Asymptomatic Malaria.

Authors:  Mallika Imwong; Kasia Stepniewska; Rupam Tripura; Thomas J Peto; Khin Maung Lwin; Benchawan Vihokhern; Klanarong Wongsaen; Lorenz von Seidlein; Mehul Dhorda; Georges Snounou; Lilly Keereecharoen; Pratap Singhasivanon; Pasathorn Sirithiranont; Jem Chalk; Chea Nguon; Nicholas P J Day; Francois Nosten; Arjen Dondorp; Nicholas J White
Journal:  J Infect Dis       Date:  2015-12-17       Impact factor: 5.226

9.  Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions.

Authors:  Julia Mwesigwa; Jane Achan; Gian Luca Di Tanna; Muna Affara; Musa Jawara; Archibald Worwui; Majidah Hamid-Adiamoh; Fatoumatta Kanuteh; Sainey Ceesay; Teun Bousema; Chris Drakeley; Koen Peeters Grietens; Steve W Lindsay; Jean-Pierre Van Geertruyden; Umberto D'Alessandro
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

10.  A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.

Authors:  Natalie J Dial; Serign J Ceesay; Roly D Gosling; Umberto D'Alessandro; Kimberly A Baltzell
Journal:  Malar J       Date:  2014-02-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.